Berit Feiring

1.4k citations

38 papers · 1.0k indexed · h-index 15

Impact in

Microbiology top 1%
- Bacterial Infections and Vaccines
Health top 5%
- Vaccine Coverage and Hesitancy

Papers in ⓘ

Microbiology 10
- Bacterial Infections and Vaccines 10
Health 13
- Vaccine Coverage and Hesitancy 13

Co-authors: Hanne Nøkleby (14 shared papers)Lill Trogstad (23 shared papers)Per Magnus (12 shared papers)Philipp Oster (6 shared papers)Ida Laake (19 shared papers)Inger Cappelen (4 shared papers)Preben Aavitsland (4 shared papers)Sandrine Tilman (4 shared papers)
Journals: Vaccine (9 papers)Clinical and Vaccine Immunology (3 papers)The Journal of Infectious Diseases (3 papers)BMJ Open (2 papers)Clinical Epidemiology (2 papers)
Partner nations: Norway Sweden Finland

In The Last Decade

Berit Feiring

38 papers receiving 989 citations

Peers

Countries citing papers authored by Berit Feiring

Since Specialization

Citations

This map shows the geographic impact of Berit Feiring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berit Feiring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berit Feiring more than expected).

Fields of papers citing papers by Berit Feiring

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Berit Feiring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berit Feiring. The network helps show where Berit Feiring may publish in the future.

Co-authors

The 25 scholars most cited alongside Berit Feiring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Berit Feiring Line = papers co-authored together Berit Feiring links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Risk of Fetal Death after Pandemic Influenza Virus Infection or Vaccination New England Journal of Medicine ·Siri E. Håberg, Lill Trogstad, Nina Gunnes, Allen J. Wilcox, Håkon K. Gjessing, Sven Ove Samuelsen, Anders Skrondal, Inger Cappelen, Anders Engeland, Preben Aavitsland, Steinar Madsen, Ingebjørg Buajordet, Kari Furu, Per Nafstad, Dan J. Stein, Berit Feiring, Hanne Nøkleby, Per Magnus, Camilla Stoltenberg	2013	218
2	Bactericidal antibodies after vaccination with the Norwegian meningococcal serogroup B outer membrane vesicle vaccine: a brief survey. PubMed ·E. Arne Høiby, Einar Rosenqvist, L O Frøholm, G Bjune, Berit Feiring, Hanne Nøkleby, E Rønnild	1991	86
3	The concept of ?tailor-made?, protein-based, outer membrane vesicle vaccines against meningococcal disease Vaccine ·J HOLST, Berit Feiring, L NASS, Gunnstein Norheim, Paul A. Kristiansen, E. Arne Høiby, Klaus Bryn, Philipp Oster, Paolo Costantino, M. P. M. Taha	2005	78
4	The Norwegian immunisation register – SYSVAK Eurosurveillance ·Lill Trogstad, G Ung, Maria Elisabeth Hagerup-Jenssen, Inger Cappelen, Inger Lise Haugen, Berit Feiring	2012	73
5	Safety review: Two outer membrane vesicle (OMV) vaccines against systemic Neisseria meningitidis serogroup B disease Vaccine ·Hanne Nøkleby, Preben Aavitsland, Jane O’Hallahan, Berit Feiring, Sandrine Tilman, Philipp Oster	2007	69
6	Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults: Beginning of epidemic control Vaccine ·V THORNTON, Diana Lennon, Kumanan Rasanathan, Jane O’Hallahan, Philipp Oster, Joanna Stewart, Sandrine Tilman, Ingeborg S. Aaberge, Berit Feiring, Hanne Nøkleby	2005	58
7	Immunogenicity and Safety of a Combination of Two Serogroup B Meningococcal Outer Membrane Vesicle Vaccines Clinical and Vaccine Immunology ·Synne Sandbu, Berit Feiring, Philipp Oster, Oddveig S. Helland, Hilde Bakke, Lisbeth Meyer Næss, Audun Aase, Ingeborg S. Aaberge, Anne-Cathrine Kristoffersen, Kjersti Margrethe Rydland, Sandrine Tilman, Hanne Nøkleby, Einar Rosenqvist	2007	49
8	Do parental education and income matter? A nationwide register-based study on HPV vaccine uptake in the school-based immunisation programme in Norway BMJ Open ·Berit Feiring, Ida Laake, Tor Molden, Inger Cappelen, Siri E. Håberg, Per Magnus, Ólöf Anna Steingrímsdóttir, Bjørn Heine Strand, Jeanette Stålcrantz, Lill Trogstad	2015	48
9	HPV vaccination and risk of chronic fatigue syndrome/myalgic encephalomyelitis: A nationwide register-based study from Norway Vaccine ·Berit Feiring, Ida Laake, Inger Johanne Bakken, Margrethe Greve‐Isdahl, Vegard Bruun Wyller, Siri E. Håberg, Per Magnus, Lill Trogstad	2017	48
10	Persisting Immune Responses Indicating Long-Term Protection after Booster Dose with Meningococcal Group B Outer Membrane Vesicle Vaccine Clinical and Vaccine Immunology ·Berit Feiring, J. E. Fuglesang, Philipp Oster, Lisbeth Meyer Næss, Oddveig S. Helland, Sandrine Tilman, Einar Rosenqvist, Marianne A. Riise Bergsaker, Hanne Nøkleby, Ingeborg S. Aaberge	2006	43
11	Substantial Decline in Prevalence of Vaccine-Type and Nonvaccine-Type Human Papillomavirus (HPV) in Vaccinated and Unvaccinated Girls 5 Years After Implementing HPV Vaccine in Norway The Journal of Infectious Diseases ·Berit Feiring, Ida Laake, Irene Kraus Christiansen, Mona Hansen, Jeanette Stålcrantz, Ole Herman Ambur, Per Magnus, Christine Monceyron Jonassen, Lill Trogstad	2018	38
12	Impact and cost-effectiveness of strategies to accelerate cervical cancer elimination: A model-based analysis Preventive Medicine ·Allison Portnoy, Kine Pedersen, Lill Trogstad, Bo T. Hansen, Berit Feiring, Ida Laake, Megan A. Smith, Stephen Sy, Mari Nygård, Jane J. Kim, Emily A. Burger	2021	22
13	Human antibody responses after vaccination with the Norwegian group B meningococcal outer membrane vesicle vaccine: results from ELISA studies. PubMed ·Einar Rosenqvist, E. Arne Høiby, G Bjune, Klaus Bryn, O Closs, Berit Feiring, A Klem, Hanne Nøkleby, L O Frølm	1991	21
14	Heavy bleeding and other menstrual disturbances in young women after COVID-19 vaccination Vaccine ·Lill Trogstad, Ida Laake, Anna Hayman Robertson, Siri Mjaaland, Ida Henriette Caspersen, Lene Kristine Juvet, Per Magnus, Kristine Blix, Berit Feiring	2023	17
15	Time trends in HPV vaccination according to country background: a nationwide register-based study among girls in Norway BMC Public Health ·Randi Dalene Bjerke, Ida Laake, Berit Feiring, Geir Aamodt, Lill Trogstad	2021	14
16	Effectiveness of mRNA Booster Vaccination Against Mild, Moderate, and Severe COVID-19 Caused by the Omicron Variant in a Large, Population-Based, Norwegian Cohort The Journal of Infectious Diseases ·Ida Laake, Siri N. Skodvin, Kristine Blix, Ida Henriette Caspersen, Håkon K. Gjessing, Lene Kristine Juvet, Per Magnus, Siri Mjaaland, Anna Hayman Robertson, Jostein Starrfelt, Lill Trogstad, Berit Feiring	2022	14
17	Human papillomavirus prevalence and type distribution in urine samples from Norwegian women aged 17 and 21 years: A nationwide cross-sectional study of three non-vaccinated birth cohorts Papillomavirus Research ·Tor Molden, Berit Feiring, Ole Herman Ambur, Irene Kraus Christiansen, Mona Hansen, Ida Laake, Roger Meisal, Ellen Myrvang, Christine Monceyron Jonassen, Lill Trogstad	2016	13
18	Trends in Antibiotic Use in Danish, Finnish, Norwegian and Swedish Children Clinical Epidemiology ·Nils Skajaa, Lise Gehrt, Heta Nieminen, Ida Laake, Hélène Englund, Ute Wolff Sönksen, Berit Feiring, Christine Stabell Benn, Lill Trogstad, Arto A. Palmu, Signe Sørup	2022	12
19	Menstrual disturbances in 12- to 15-year-old girls after one dose of COVID-19 Comirnaty vaccine: Population-based cohort study in Norway Vaccine ·Ida Henriette Caspersen, Lene Kristine Juvet, Berit Feiring, Ida Laake, Anna Hayman Robertson, Siri Mjaaland, Per Magnus, Lill Trogstad	2022	12
20	Determinants of humoral and cellular immune responses to three doses of mRNA SARS-CoV-2 vaccines in older adults: a longitudinal cohort study The Lancet Healthy Longevity ·Anthony Ravussin, Anna Hayman Robertson, Asia‐Sophia Wolf, Kristine Blix, Ingrid Fadum Kjønstad, Guri Solum, Berit Feiring, Bjørn Heine Strand, Fridtjof Lund‐Johansen, Ludvig A. Munthe, Per Magnus, Lill Trogstad, Siri Mjaaland	2023	11

About Berit Feiring

Berit Feiring is a scholar working on Microbiology, Health, Modeling and Simulation, Epidemiology and Obstetrics and Gynecology, having authored 38 papers that have together received 1.0k indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (13 papers), Pneumonia and Respiratory Infections (11 papers), Bacterial Infections and Vaccines (10 papers), Cervical Cancer and HPV Research (7 papers), Influenza Virus Research Studies (6 papers), Hepatitis B Virus Studies (6 papers), COVID-19 Impact on Reproduction (4 papers) and Immune responses and vaccinations (4 papers). The work is most often cited by research in Microbiology (433 citations), Health (242 citations), Epidemiology (782 citations), Obstetrics and Gynecology (90 citations) and Infectious Diseases (124 citations). Berit Feiring has collaborated with scholars based in Norway, Sweden and Finland. Frequent co-authors include Hanne Nøkleby, Lill Trogstad, Per Magnus, Philipp Oster, Ida Laake, Inger Cappelen, Preben Aavitsland, Sandrine Tilman, Siri E. Håberg and Einar Rosenqvist. Their work appears in journals such as Vaccine, Clinical and Vaccine Immunology, The Journal of Infectious Diseases, BMJ Open and Clinical Epidemiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact